US NUCLEAR'S
PARTNER MIFTI TAKES GIANT LEAD IN
$3
TRILLION
RACE
FOR CLEAN ENERGY
Atlanta,
GA -- April 26, 2019 -- InvestorsHub NewsWire
-- Emerging MicroCaps
-- US Nuclear Corp. (USOTC:
UCLE)
-
Fusion
Thermonuclear Energy powers the stars and is the
ultimate
energy source that is clean, cheap and unlimited because its fuel
is an isotope of seawater.
-
The prize of
harnessing Nuclear Fusion is so big that it has lured
prominent
investors such
as Bill Gates, Jeff Bezos, Paul Allen,
Art Samburg
and
others.
-
The University
of Nevada Reno National Terawatt
Facility recently witnessed the biggest historic event in history
of fusion energy when
MIFTI/MIFTEC achieved neutron flux in excess of
1010
that is estimated to be
over 100,000 times more powerful than any
other
private endeavor in history.
-
Nuclear Plasma
Engineer has completed design plans for first Staged Z Pinch
(SZP) LTD-X (linear transformer driver-X)
10 MegaAmp
generator
that will be
used to produce commercial
medical
radioisotopes and the
machine
is now
ready to
begin
building.
The larger
MIFGEN generator
for electric
power production for the grid will follow
next.
-
US
Nuclear, a leading nuclear
company owns
substantial
interests
in
both MIFTI and MIFTEC and has rights to manufacture and sell
their
fusion
generators to produce
medical radioisotopes and power for the electric power
grid.
US Nuclear Corp. (OTC:
UCLE) and Magneto-Inertial Fusion Technologies, Inc. (MIFTI)
have
signed an agreement which grants US Nuclear
500,000 shares of Magneto-Inertial Fusion Technologies, Inc.
(MIFTI) stock, the option to acquire up to 10% (ten percent) of
MIFTI, and non-exclusive worldwide rights to manufacture and sell
MIFTI's patented thermonuclear fusion power
generator. MIFTI's fusion power generator
is expected to produce clean, base load
electric power for the US and other power grids and wherever small
modular electric power sources are needed. The worldwide energy
market is estimated to reach $6 trillion by 2030.
Last year, US Nuclear signed
a similar agreement with MIFTEC Labs for a revolutionary new way to
produce medical radioisotopes from nuclear fusion power that has
several substantial
cost and safety
advantages over the current nuclear fission-based
methods.
MIFTI and MIFTEC are sister
companies under the same management and are developing and using
the same "staged Z-PINCH fusion technology" for
different
applications and markets.
MIFTI is developing
thermonuclear fusion energy to power cities, transportation, space
vehicles, military vehicles, and ships from fusion; and MIFTEC is
developing a fusion-based generator for the abundant production of
low-cost medical isotopes, which are currently in very short
supply.
US Nuclear plans a series of
future announcements relative to both MIFTEC and MIFTI
developments.
Energy from nuclear fusion
has been a dream for decades. It is the same nuclear energy that
powers our sun and the stars. Fusion power is many times greater
than the power derived from fossil fuels or even from our fission
nuclear reactors, and is a source of clean energy since the fuel is
derived from seawater rather than from radioactive uranium or the
pollution generating, carbon-based fuels now in use. The
development of fusion power has been elusive and the
several-decade long endeavor
has created a
common perception that fusion energy is still many decades in the
future. However, recent experiments by MIFTI and MIFTEC at the
highly regarded University of Nevada, Reno National Terawatt
Facility (UNR/NTF), have achieved historic results that suggest
harnessing the power of nuclear fusion may be closer than
realized. There is great controversy
over the effects of fossil fuels on global warming and climate
change. If successful, fusion energy has the potential to usher in
a new era of low cost, clean energy.
In the time since US Nuclear
partnered with MIFTEC Labs, MIFTEC has succeeded, at the University
of Reno Nevada National Terawatt Facility, in generating the most
powerful neutron flux from fusion power ever achieved by a private
company. Using a 1 MegaAmp machine, this experiment
achieved a neutron flux in excess of 1010,
(ten to the tenth power) demonstrating that they are
doing things right. Next comes a larger 10 MegaAmp version of their machine that
is expected to generate a neutron flux of 1012
which is clearly
greater than the 1010
and is
required to
produce commercial quantities of critical, low-cost radioisotopes
that are in short supply. Shortly thereafter, MIFTEC contracted
with a leading design engineer from a National Lab and has already
completed the plans for its first commercial machine called the
Staged Z Pinch (SZP) LTD-X (linear transformer driver-X) 10 MegaAmp generator. U.S Nuclear and the MIFTI
team now look forward to building the first machine.
Jerry Simmons, MIFTI and
MIFTEC CEO, says, "Plans are
underway for further testing to provide base load electricity to
the power grid, and with the kind of results we have already
achieved at an independent testing laboratory, we are confident
that we have a solution to provide the world with safe, clean,
low-cost energy.
Other
advantages of fusion power include no nuclear waste that can be
used to proliferate nuclear weapons.
In
addition, MIFTI's fusion generators are scalable and compact
compared to all other energy production footprints."
Emerging MicroCaps finds US Nuclear
undervalued at current share price and
market cap respectively of $1.45 and $25 million. Based
on current sales alone, at typical Price to Sales ratio
20 to 1 for an
early stage growth company, a fair market price and market cap
would be $4.06 and $70 million. When factoring in future potential
growth from the medical radioisotope and the fusion energy profit
centers, and the low number of outstanding shares of 17 million and
a float of about 7 million shares, substantially higher prices can
be justified. Shares are thinly traded and volatile and could
experience what would be considered very large moves.
Management is highly experienced in nuclear physics and is
conservative and is executing an excellent growth
strategy.
US Nuclear is a solid growth
company even without the announcements of their disruptive
breakthroughs in the $10 billion medical radioisotope market, and
the $3 trillion energy market where their solution may be able to
provide unlimited power at very low cost, but perhaps most
importantly, because energy from fusion power is clean and leaves
no carbon footprint.
Emerging MicroCaps rates US Nuclear a Strong Buy
and Hold.
About US Nuclear
US Nuclear Corporation is a
world leading manufacturer of advanced radiation and chemical
detection and UAV instrumentation.
About MIFTI
MIFTI is a Department of
Energy Advanced Research Projects Agency – Energy (DOE/ARPA-E)
awardee and benefits from support by the National Nuclear Security
Administration (NNSA). MIFTI also holds a fully executed work
package agreement with Oak Ridge National Laboratory (ORNL), and is
in negotiations for a work package agreement with Savannah River
National Laboratory (SRNL). The National Aeronautics and Space
Administration (NASA) has shown interest in using MIFTI
thermonuclear fusion power devices for use in space craft
propulsion systems. The U.S. Navy has also shown
an interest in MIFTI's fusion power device for use in nuclear
submarines and aircraft carriers.
Safe Harbor
Act
This press release includes
"forward-looking statements" within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Actual results may differ from expectations,
estimates and projections and, consequently, you should not rely on
these forward looking statements as predictions of future events.
Words such as "expect," "estimate," "project," "budget,"
"forecast," "anticipate," "intend," "plan," "may," "will," "could,"
"should," "believes," "predicts," "potential," "continue," and
similar expressions are intended to identify such forward-looking
statements. These forward-looking statements involve significant
risks and uncertainties that could cause the actual results to
differ materially from the expected results.
Investors may find additional
information regarding US Nuclear Corp. at the SEC website at
http://www.sec.gov, or the company's website at
www.usnuclearcorp.com
Contact:
Emerging MicroCaps
Atlanta,
GA
EmergingMicroCaps.com
US Nuclear
Corp. (USOTC:
UCLE)
SOURCE: Emerging MicroCaps